Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity

F Mussai, S Egan, S Hunter, H Webber, J Fisher… - Cancer research, 2015 - AACR
Neuroblastoma is the most common extracranial solid tumor of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …
被引用次数：117 相关文章

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

F Mussai, S Egan, S Hunter, H Webber… - Cancer …, 2015 - research.birmingham.ac.uk
Neuroblastoma is the most common extracranial solid tumor of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

F Mussai, S Egan, S Hunter, H Webber, J Fisher… - Cancer …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Neuroblastoma is the most common
extracranial solid tumor of childhood, and survival remains poor for patients with advanced …
[HTML] nih.gov

[HTML][HTML] Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity

F Mussai, S Egan, S Hunter, H Webber, J Fisher… - Cancer …, 2015 - ncbi.nlm.nih.gov
Neuroblastoma is the most common extra cranial solid tumour of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …

Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity

F Mussai, SA Egan, S Hunter, H Webber… - Cancer … - eprints.nottingham.ac.uk
Neuroblastoma is the most common extra cranial solid tumour of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

F Mussai, S Egan, S Hunter, H Webber, J Fisher… - 2015 - repository.icr.ac.uk
Neuroblastoma is the most common extracranial solid tumor of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

F Mussai, S Egan, S Hunter, H Webber… - Cancer …, 2015 - sure.sunderland.ac.uk
Neuroblastoma is the most common extracranial solid tumor of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …
[PDF] worktribe.com

[PDF][PDF] Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity

F Mussai, S Egan, S Hunter… - Cancer …, 2015 - nottingham-repository.worktribe.com
Neuroblastoma is the most common extra cranial solid tumour of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …

Neuroblastoma arginase activity creates an immunosuppressive microenvironment impairing autologous and engineered immunity

F Mussai, S Egan, S Hunter, H Webber, J Fisher… - Cancer …, 2015 - dspace.stir.ac.uk
Neuroblastoma is the most common extracranial solid tumor of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

F Mussai, S Egan, S Hunter, H Webber, J Fisher… - Cancer …, 2015 - europepmc.org
Neuroblastoma is the most common extra cranial solid tumour of childhood, and survival
remains poor for patients with advanced disease. Novel immune therapies are currently in …